Based on tumor-targeting ability and the inhibition of the STAT3 and NF-κB signaling pathways, we then investigated the anti-tumor effect and the immune environment remodeling in the BCa model (Fig. 5A). The gene discussed is NFKB1; the disease is neoplasm.